| [1]Zur Hausen H.Human paillomvirus in human cancer[J].Cancer,1987,59(10):1690-[2]Cheah PL，Lool LM.P53 immunohistochemical exipression： messages in cervical carcinogenesis[J].Pathology,2002,34(4):326-331[3]TunstallPedoe H.Preventing chronic diseasesA vital investment：WHO global report． Geneva： World Health Organization[J].． Int J Epidemiol,2006,19(1):200-218[4]Duensing S，Munger K.Centro some abnormalities and genomic instability induced by human papilloma virus on proteins[J].Prog Cell Cycle Ｒes,2003,5:383-391[5]Scully C,Prime S,Maitland N.Papillomaviruses: their possible role in oral disease[J].Oral Surg Oral Med Oral Path,1985,60(2):166-174[6]梅建军,樊明文.乳头状瘤病毒与口腔黏膜病损关系的研究现状[J].口腔医学纵横,1989,5(1):46-48[7]卢勇,扬怀涛,周志瑜,等.人类乳头状瘤病毒与口腔黏膜鉴别的关系[J].口腔颌面外科杂志,1993,1(3):32-35[8]赵泓森，姜艳波，陈新英，等.人乳头状瘤病毒和口腔鳞癌关系的研究[J].口腔医学研究,2014,7(30):685-687[9]胡婷，卢树静，陈谦明，等.口腔黏膜人乳头瘤病毒感染的研究现状[J].临床口腔医学杂志,2012,9(28):569-578[10]Correnti M,Rossi M,Avila M,et al.Human papillomavirus in ameloblastoma[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2010,110(3):e-[11]Khaskhely NM,Vezato H,Kamiyama T,et al.Association of human Papillomavirus type 6 with a verruciform xanthoma[J].Am J Dermatopathol,2000,22(5):447-452[12]Rohwedder A,Murphy M,Carlson FA.Multipe HPV DNA indentified in verruciform xanfhoma by nested polymerase chain reaction with degenerate consensus peimers[J].J Cutaneous Pathol,2003,30(5):344-346[13]Miller CS，White DK.Human papillomavirus expression in oral mucosa，premalignant conditions，and squamous cell carcinomaA retrospective review of the literature[J].． Oral Surg Oral Med Oral Pathol Oral Radiol Endod,1996,82(1):57-68[14]Campisi G，Giovannelli L，Aricò P，et al.HPV DNA in clinically different variants of oral leukoplakia and lichen planus[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2004,98(6):705-711[15]Nielsen H，Norrild B，Vedtofte P，et al.Human papillomavirus in oral premalignant lesions[J].Eur J Cancer B Oral Oncol,1996,32(4):264-270[16]Ostwald C，Rutsatz K，Schweder J，et al.Human papillomavirus 6/11，16 and 18 in oral carcinomas and benign oral lesions[J].Med Microbiol Immunol,2003,192(3):145-148[17]Palefsky JM，Silverman Jr S，AbdelSalaam M，et al.Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16[J].J Oral Pathol Med,1995,24(5):193-197[18]Miller C，Johnstone B.Human papillomavirus as a risk factor for oral squamous cell carcinoma[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2001,91(6):622-635[19]Bagan JV，Jimenez Y，Murillo J，et al.Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection[J].J Oral Maxillofac Surg,2007,65(1):46-49[20]Campisi G，Giovannelli L，Ammatuna P，et al.Proliferative verrucous vs conventional leukoplakia：no significantly increased risk of HPV infection[J].Oral Oncol,2004,40(8):835-840[21]Kumaraswamy KL，Vidhya M.Human papilloma virus and oral infections：an update[J].J Cancer Res Ther,2011,7(2):120-127[22].刘锡光，刘忠，田厚文． 人乳头瘤病毒感染及其防治［M］． 北京：人民卫生出版社，2009：12-16，33-43，78，96-97，171-177．[23]Terai M，Takagi M.Human papillomavirus in the oral cavity[J].Oral Med Pathol,2001,6(1):1-12[24]Khan MJ，Castle PE，Lorincz AT，et al.The elevated 102005 risk of cervical precancer and Cancer in women with human papillomavirus（HPV） type 16 or 18 and the possible utility of typespecific HPV testing in clinical practice[J].J Natl Cancer Inst,2005,97(14):1072-1079[25]Villiers EM，Fauquet C，Broker TR，et al.Classification of papillomaviruses[J].Virology,2004,324(1):17-27[26]Rautava J，Syrjnen S.Human papillomavirus infections in the oral mucosa[J].J Am Dent Assoc,2011,142(8):905-914[27]Lacour DE，Trimble C.Human papillomavirus in infants：transmission，prevalence，and persistence[J].J Pediatr Adolesc Gynecol,2012,25(2):93-97[28]Szarka K,Tar L,Feher E,et al.Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential[J].Oral Microbiol Immunol,2009,24(4):314-318[29]Syrjnen S,Lodi G,von Bültzingslwen I.Human papillomaviruses in oral carcinoma and oral potentially malignant disorders：a systematic review[J].Oral Dis,2011,17(sl):58-72[30]Zhu C,Ling Y,Dong C,et al.The relationship between oral squamous cell carcinoma and human papillomavirus： a metaanalysis of a Chinese population （1994—2011）[J].PLoS One,2012,7(5):e36294-[31].Byemon AB，Peters ES，Coughlin SS，et al．Burden of potentially human papillomavirusassociated cancem of the oropharynx and ondcavity in tIIe US，1998—2003［J］．Cancer，2008，113 （10 Suppl）：：2901-2909．[32]Gillison ML,DSouza G,Westra W,et al.Distinct risk factor profiles for human papillomavirus type 16positive and human papillomavirus type 16negative head and neck cancers[J].J Natl Cancer Inst,2008,100(6):407-420[33]Romanowski B.Long term protection against cervical infection with[34]the human papillomavirus：review of currently available vaccines［J］.Hum Vaccin，2011，7（2）：161-169.[35]Vermorken JB，SthlmacherWilliams J，Davidenko I，et al.Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamouscell carcinoma of the head and neck（SPECTRUM）：an openlabel phase 3 randomisedtria[J].Lancet Oncol,2013,14(8):697-710[36]Gillison ML,Broutian T,Pickard RK,et al.Prevalence of oral HPV infection in the United States,2009—2011[J].JAMA,2012,307(7):693-703 |
